171 related articles for article (PubMed ID: 34415831)
1. Cullin-5 (CUL5) as a potential prognostic marker in a pan-cancer analysis of human tumors.
Li Z; Hu N; Dai L; Hou X; Hu W; Liang W; Wang X
Bioengineered; 2021 Dec; 12(1):5348-5360. PubMed ID: 34415831
[TBL] [Abstract][Full Text] [Related]
2. Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes.
Yu Q; Hu Z; Shen Y; Jiang Y; Pan P; Hou T; Pan ZQ; Huang J; Sun Y
Neoplasia; 2020 Apr; 22(4):179-191. PubMed ID: 32145688
[TBL] [Abstract][Full Text] [Related]
3. The CUL5 E3 ligase complex negatively regulates central signaling pathways in CD8
Liao X; Li W; Zhou H; Rajendran BK; Li A; Ren J; Luan Y; Calderwood DA; Turk B; Tang W; Liu Y; Wu D
Nat Commun; 2024 Jan; 15(1):603. PubMed ID: 38242867
[TBL] [Abstract][Full Text] [Related]
4. E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cells.
Samant RS; Clarke PA; Workman P
Proc Natl Acad Sci U S A; 2014 May; 111(18):6834-9. PubMed ID: 24760825
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases.
Mahrour N; Redwine WB; Florens L; Swanson SK; Martin-Brown S; Bradford WD; Staehling-Hampton K; Washburn MP; Conaway RC; Conaway JW
J Biol Chem; 2008 Mar; 283(12):8005-13. PubMed ID: 18187417
[TBL] [Abstract][Full Text] [Related]
6. Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182.
Devor EJ; Schickling BM; Reyes HD; Warrier A; Lindsay B; Goodheart MJ; Santillan DA; Leslie KK
Oncol Rep; 2016 Apr; 35(4):2461-5. PubMed ID: 26847831
[TBL] [Abstract][Full Text] [Related]
7. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of intersubunit recognition in elongin BC-cullin 5-SOCS box ubiquitin-protein ligase complexes.
Kim YK; Kwak MJ; Ku B; Suh HY; Joo K; Lee J; Jung JU; Oh BH
Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1587-97. PubMed ID: 23897481
[TBL] [Abstract][Full Text] [Related]
9. Gold nanoparticles loaded with cullin-5 DNA increase sensitivity to 17-AAG in cullin-5 deficient breast cancer cells.
Talamantez-Lyburn S; Brown P; Hondrogiannis N; Ratliff J; Wicks SL; Nana N; Zheng Z; Rosenzweig Z; Hondrogiannis E; Devadas MS; Ehrlich ES
Int J Pharm; 2019 Jun; 564():281-292. PubMed ID: 30999048
[TBL] [Abstract][Full Text] [Related]
10. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
Kamura T; Maenaka K; Kotoshiba S; Matsumoto M; Kohda D; Conaway RC; Conaway JW; Nakayama KI
Genes Dev; 2004 Dec; 18(24):3055-65. PubMed ID: 15601820
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of VACM-1/cul5 exons in cancer cell lines.
Lewis SP; Willis AN; Johnson AE; Resau J; Burnatowska-Hledin MA
APMIS; 2011 Jul; 119(7):421-30. PubMed ID: 21635549
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of VACM-1/Cul5 by protein kinase A regulates its neddylation and antiproliferative effect.
Bradley SE; Johnson AE; Le IP; Oosterhouse E; Hledin MP; Marquez GA; Burnatowska-Hledin M
J Biol Chem; 2010 Feb; 285(7):4883-95. PubMed ID: 19917606
[TBL] [Abstract][Full Text] [Related]
13. Cullin 5 destabilizes Cas to inhibit Src-dependent cell transformation.
Teckchandani A; Laszlo GS; Simó S; Shah K; Pilling C; Strait AA; Cooper JA
J Cell Sci; 2014 Feb; 127(Pt 3):509-20. PubMed ID: 24284072
[TBL] [Abstract][Full Text] [Related]
14. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
15. miR-19a promotes the metastasis and EMT through CUL5 in prostate cancer cell line PC3.
Wang Y; Hu J; Qi G; Wang S; Gao J
J BUON; 2020; 25(4):2028-2035. PubMed ID: 33099949
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
Liu B; Sarkis PT; Luo K; Yu Y; Yu XF
J Virol; 2005 Aug; 79(15):9579-87. PubMed ID: 16014920
[TBL] [Abstract][Full Text] [Related]
17. New insights into the mechanism for VACM-1/cul5 expression in vascular tissue in vivo.
Burnatowska-Hledin MA; Barney CC
Int Rev Cell Mol Biol; 2014; 313():79-101. PubMed ID: 25376490
[TBL] [Abstract][Full Text] [Related]
18. Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5.
Baxter SS; Carlson LA; Mayer AM; Hall ML; Fay MJ
In Vitro Cell Dev Biol Anim; 2009; 45(5-6):264-74. PubMed ID: 19118439
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Gao F; Sun X; Wang L; Tang S; Yan C
Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
[TBL] [Abstract][Full Text] [Related]
20. VACM-1/cul5 expression in vascular tissue in vivo is induced by water deprivation and its expression in vitro regulates aquaporin-1 concentrations.
Johnson AE; Le IP; Andresen BT; Stodola J; Dewey GL; Dean SB; Resau J; Haak P; Ruch T; Sartor A; Lazdins I; Barney CC; Burnatowska-Hledin MA
Cell Tissue Res; 2012 Aug; 349(2):527-39. PubMed ID: 22581383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
